Dongjak Gu
Dongjak Gu
Dongjak Gu, Seoul, South Korea3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR) | Papulopustular Rosacea, Skin and Connective Tissue Diseases, primary hyperoxaluria type 2, rosacea, skin disorder | Recruiting | Phase 2 | 2026-09-28 | NCT07681271 | |
| Remibrutinib Open Label Roll-over Post-trial Access Protocol | Indication of the Parent Protocol | Recruiting | Phase 3 | 2026-09-25 | NCT07456891 | |
| A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder | Recruiting | Phase 3 | 2026-09-22 | NCT07326709 |